Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer

por Bazargan, Sarah, Bunch, Brittany, Ojwang‘, Awino Maureiq E., Blauvelt, Jamie, Landin, Annick, Ali, Johannes, Abrahams, Dominique, Cox, Cheryl, Hall, Amy M., Beatty, Matthew S., Poch, Michael, Rejniak, Katarzyna A., Pilon-Thomas, Shari
Publicado 2023

SARS-CoV-2 antibody response duration and neutralization following natural infection

por Dukes, Christopher W, Rossetti, Renata AM, Hensel, Jonathan A, Snedal, Sebastian, Cubitt, Christopher L, Schell, Michael J, Abrahamsen, Martha, Isaacs-Soriano, Kimberly, Kennedy, Kayoko, Mangual, Leslie N, Whiting, Junmin, Martinez-Brockhus, Veronica, Islam, Jessica Y, Rathwell, Julie, Beatty, Matthew, Hall, Amy M, Abate-Daga, Daniel, Giuliano, Anna R, Pilon-Thomas, Shari
Publicado 2023

Neoantigen-specific CD4(+) tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

por Hall, MacLean S., Teer, Jamie K., Yu, Xiaoqing, Branthoover, Holly, Snedal, Sebastian, Rodriguez-Valentin, Madeline, Nagle, Luz, Scott, Ellen, Schachner, Ben, Innamarato, Patrick, Hall, Amy M., Blauvelt, Jamie, Rich, Carolyn J., Richards, Allison D., Ceccarelli, Jake, Langer, TJ, Yoder, Sean J., Beatty, Matthew S., Cox, Cheryl A., Messina, Jane L., Abate-Daga, Daniel, Mule, James J., Mullinax, John E., Sarnaik, Amod A., Pilon-Thomas, Shari
Publicado 2023